Skip to content

Clinical trials

Lung Diseases, Obstructive trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Obstructive Country / region: France Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20101
20121
20131
20144
20151
20163
20171
20181
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Assistance Publique - Hôpitaux de Paris3
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche1
Centre Hospitalier Universitaire de Saint Etienne1
Groupe Hospitalier du Havre1
Novartis Pharmaceuticals1
University Hospital, Strasbourg, France1
University Hospital, Toulouse1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Obstructive17
Lung Diseases10
Asthma9
Bronchial Diseases8
Respiratory Tract Diseases8
Pulmonary Disease, Chronic Obstructive3
Bronchiolitis Obliterans2
Hypersensitivity2
Immune System Diseases2
Bronchiolitis1

Trials

Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.